From: Clinical significance of polyglutamylation in primary central nervous system lymphoma
 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Variable | HR (95% CI) | p | HR (95% CI) | p |
Age | 1.015 (0.995–1.036) | 0.14 | 1.005 (0.972–1.038) | 0.79 |
KPS (high vs. low) | 1.328 (0.784–2.250) | 0.29 | 0.717 (0.340–1.513) | 0.38 |
Sex (M vs. F) | 1.531 (0.953–2.457) | 0.078 | 1.445 (0.820–2.545) | 0.20 |
MSKCC score | 1.151 (0.819–1.619) | 0.42 | 0.782 (0.410–1.491) | 0.46 |
Cell of origin (GCB vs. non-GCB) | 0.696 (0.407–1.191) | 0.19 | 1.086 (0.576–2.048) | 0.80 |
LDH (high vs. normal range) | 1.306 (0.801–2.129) | 0.29 | 1.532 (0.860–2.731) | 0.15 |
Location (deep vs. not deep) | 0.928 (0.531–1.622) | 0.79 | 1.377 (0.732–2.587) | 0.32 |
Polyglutamylation vs. non-polyglutamylation | 0.439 (0.269–0.716) | 0.0010 | 0.461 (0.259–0.823) | 0.0087 |